참고문헌
- Siegel, R., Desantis, C. and Jemal, A. (2014) Colorectal cancer statistics, 2014. Ca Cancer J. Clin., 64, 104-117. https://doi.org/10.3322/caac.21220
- Douillard, J.Y., Cunningham, D., Roth, A.D., Navarro, M., James, R.D., Karasek, P., Jandik, P., Iveson, T., Carmichael, J., Alakl, M., Gruia, G., Awad, L. and Rougier, P. (2000) Irinotecan combined with fluorouracil compared with fluorouracil alone as first-line treatment for metastatic colorectal cancer: a multicentre randomised trial. Lancet, 355, 1041-1047. https://doi.org/10.1016/S0140-6736(00)02034-1
- Longley, D.B., Harkin, D.P. and Johnston, P.G. (2003) 5-fluorouracil: mechanisms of action and clinical strategies. Nat. Rev. Cancer, 3, 330-338. https://doi.org/10.1038/nrc1074
- Park, I.J., You, Y.N., Agarwal, A., Skibber, J.M., Rodriguez-Bigas, M.A., Eng, C., Feig, B.W., Das, P., Krishnan, S., Crane, C.H., Hu, C.Y. and Chang, G.J. (2012) Neoadjuvant treatment response as an early response indicator for patients with rectal cancer. J. Clin. Oncol., 30, 1770-1776. https://doi.org/10.1200/JCO.2011.39.7901
- Thiery, J.P. (2002) Epithelial-mesenchymal transitions in tumour progression. Nat. Rev. Cancer, 2, 442-454. https://doi.org/10.1038/nrc822
- Peinado, H., Olmeda, D. and Cano, A. (2007) Snail, Zeb and bHLH factors in tumour progression: an alliance against the epithelial phenotype? Nat. Rev. Cancer, 7, 415-428. https://doi.org/10.1038/nrc2131
- Kang, Y. and Massague, J. (2004) Epithelial-mesenchymal transitions: twist in development and metastasis. Cell, 118, 277-279. https://doi.org/10.1016/j.cell.2004.07.011
- Vandewalle, C., Comijn, J., De Craene, B., Vermassen, P., Bruyneel, E., Andersen, H., Tulchinsky, E., Van Roy, F. and Berx, G. (2005) SIP1/ZEB2 induces EMT by repressing genes of different epithelial cell-cell junctions. Nucleic Acids Res., 33, 6566-6578. https://doi.org/10.1093/nar/gki965
- Lombaerts, M., van Wezel, T., Philippo, K., Dierssen, J.W., Zimmerman, R.M., Oosting, J., van Eijk, R., Eilers, P.H., van de Water, B., Cornelisse, C.J. and Cleton-Jansen, A.M. (2006) E-cadherin transcriptional downregulation by promoter methylation but not mutation is related to epithelial-to-mesenchymal transition in breast cancer cell lines. Br. J. Cancer, 94, 661-671. https://doi.org/10.1038/sj.bjc.6602996
- Rosano, L., Cianfrocca, R., Spinella, F., Di Castro, V., Nicotra, M.R., Lucidi, A., Ferrandina, G., Natali, P.G. and Bagnato, A. (2011) Acquisition of chemoresistance and EMT phenotype is linked with activation of the endothelin A receptor pathway in ovarian carcinoma cells. Clin. Cancer Res., 17, 2350-2360. https://doi.org/10.1158/1078-0432.CCR-10-2325
- Rho, J.K., Choi, Y.J., Lee, J.K., Ryoo, B.Y., Na, I.I., Yang, S.H., Kim, C.H. and Lee, J.C. (2009) Epithelial to mesenchymal transition derived from repeated exposure to gefitinib determines the sensitivity to EGFR inhibitors in A549, a non-small cell lung cancer cell line. Lung Cancer, 63, 219-226. https://doi.org/10.1016/j.lungcan.2008.05.017
- Kajiyama, H., Shibata, K., Terauchi, M., Yamashita, M., Ino, K., Nawa, A. and Kikkawa, F. (2007) Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells. Int. J. Oncol., 31, 277-283.
- Hiscox, S., Jiang, W.G., Obermeier, K., Taylor, K., Morgan, L., Burmi, R., Barrow, D. and Nicholson, R.I. (2006) Tamoxifen resistance in MCF7 cells promotes EMT-like behaviour and involves modulation of beta-catenin phosphorylation. Int. J. Cancer, 118, 290-301. https://doi.org/10.1002/ijc.21355
- Creighton, C.J., Li, X., Landis, M., Dixon, J.M., Neumeister, V.M., Sjolund, A., Rimm, D.L., Wong, H., Rodriguez, A., Herschkowitz, J.I., Fan, C., Zhang, X., He, X., Pavlick, A., Gutierrez, M.C., Renshaw, L., Larionov, A.A., Faratian, D., Hilsenbeck, S.G., Perou, C.M., Lewis, M.T., Rosen, J.M. and Chang, J.C. (2009) Residual breast cancers after conventional therapy display mesenchymal as well as tumor-initiating features. Pro. Natl. Acad. Sci. U.S.A., 106, 13820-13825. https://doi.org/10.1073/pnas.0905718106
- Zhang, N., Yin, Y., Xu, S.J. and Chen, W.S. (2008) 5-Fluorouracil: mechanisms of resistance and reversal strategies. Molecules, 13, 1551-1569. https://doi.org/10.3390/molecules13081551
- Herrmann, R. (1996) 5-Fluorouracil in colorectal cancer, a never ending story. Ann. Oncol., 7, 551-552. https://doi.org/10.1093/oxfordjournals.annonc.a010668
- Thomson, S., Buck, E., Petti, F., Griffin, G., Brown, E., Ramnarine, N., Iwata, K.K., Gibson, N. and Haley, J.D. (2005) Epithelial to mesenchymal transition is a determinant of sensitivity of non-small-cell lung carcinoma cell lines and xenografts to epidermal growth factor receptor inhibition. Cancer Res., 65, 9455-9462. https://doi.org/10.1158/0008-5472.CAN-05-1058
- Byers, L.A., Diao, L., Wang, J., Saintigny, P., Girard, L., Peyton, M., Shen, L., Fan, Y., Giri, U., Tumula, P.K., Nilsson, M.B., Gudikote, J., Tran, H., Cardnell, R.J., Bearss, D.J., Warner, S.L., Foulks, J.M., Kanner, S.B., Gandhi, V., Krett, N., Rosen, S.T., Kim, E.S., Herbst, R.S., Blumenschein, G.R., Lee, J.J., Lippman, S.M., Ang, K.K., Mills, G.B., Hong, W.K., Weinstein, J.N., Wistuba, I.I., Coombes, K.R., Minna, J.D. and Heymach, J.V. (2013) An epithelial-mesenchymal transition gene signature predicts resistance to EGFR and PI3K inhibitors and identifies Axl as a therapeutic target for overcoming EGFR inhibitor resistance. Clin. Cancer Res., 19, 279-290. https://doi.org/10.1158/1078-0432.CCR-12-1558
- Mani, S.A., Guo, W., Liao, M.J., Eaton, E.N., Ayyanan, A., Zhou, A.Y., Brooks, M., Reinhard, F., Zhang, C.C., Shipitsin, M., Campbell, L.L., Polyak, K., Brisken, C., Yang, J. and Weinberg, R.A. (2008) The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell, 133, 704-715. https://doi.org/10.1016/j.cell.2008.03.027
- Shipitsin, M., Campbell, L.L., Argani, P., Weremowicz, S., Bloushtain-Qimron, N., Yao, J., Nikolskaya, T., Serebryiskaya, T., Beroukhim, R., Hu, M., Halushka, M.K., Sukumar, S., Parker, L.M., Anderson, K.S., Harris, L.N., Garber, J.E., Richardson, A.L., Schnitt, S.J., Nikolsky, Y., Gelman, R.S. and Polyak, K. (2007) Molecular definition of breast tumor heterogeneity. Cancer Cell, 11, 259-273. https://doi.org/10.1016/j.ccr.2007.01.013
- Morel, A.P., Lievre, M., Thomas, C., Hinkal, G., Ansieau, S. and Puisieux, A. (2008) Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One, 3, e2888. https://doi.org/10.1371/journal.pone.0002888
- Li, X., Lewis, M.T., Huang, J., Gutierrez, C., Osborne, C.K., Wu, M.F., Hilsenbeck, S.G., Pavlick, A., Zhang, X., Chamness, G.C., Wong, H., Rosen, J. and Chang, J.C. (2008) Intrinsic resistance of tumorigenic breast cancer cells to chemotherapy. J. Natl. Cancer Inst., 100, 672-679. https://doi.org/10.1093/jnci/djn123
- Barr, S., Thomson, S., Buck, E., Russo, S., Petti, F., Sujka-Kwok, I., Eyzaguirre, A., Rosenfeld-Franklin, M., Gibson, N.W., Miglarese, M., Epstein, D., Iwata, K.K. and Haley, J.D. (2008) Bypassing cellular EGF receptor dependence through epithelial-to-mesenchymal-like transitions. Clin. Exp. Metastasis, 25, 685-693. https://doi.org/10.1007/s10585-007-9121-7
- Singh, A. and Settleman, J. (2010) EMT, cancer stem cells and drug resistance: an emerging axis of evil in the war on cancer. Oncogene, 29, 4741-4751. https://doi.org/10.1038/onc.2010.215
- Elloul, S., Elstrand, M.B., Nesland, J.M., Trope, C.G., Kvalheim, G., Goldberg, I., Reich, R. and Davidson, B. (2005) Snail, Slug, and Smad-interacting protein 1 as novel parameters of disease aggressiveness in metastatic ovarian and breast carcinoma. Cancer, 103, 1631-1643. https://doi.org/10.1002/cncr.20946
- Pena, C., Garcia, J.M., Silva, J., Garcia, V., Rodriguez, R., Alonso, I., Millan, I., Salas, C., de Herreros, A.G., Munoz, A. and Bonilla, F. (2005) E-cadherin and vitamin D receptor regulation by SNAIL and ZEB1 in colon cancer: clinicopathological correlations. Hum. Mol. Genet., 14, 3361-3370. https://doi.org/10.1093/hmg/ddi366
- Uchikado, Y., Okumura, H., Ishigami, S., Setoyama, T., Matsumoto, M., Owaki, T., Kita, Y. and Natsugoe, S. (2011) Increased Slug and decreased E-cadherin expression is related to poor prognosis in patients with gastric cancer. Gastric Cancer, 14, 41-49. https://doi.org/10.1007/s10120-011-0004-x
- Yang, J., Mani, S.A., Donaher, J.L., Ramaswamy, S., Itzykson, R.A., Come, C., Savagner, P., Gitelman, I., Richardson, A. and Weinberg, R.A. (2004) Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell, 117, 927-939. https://doi.org/10.1016/j.cell.2004.06.006
피인용 문헌
- YM155, a small molecule inhibitor of survivin expression, sensitizes cancer cells to hypericin-mediated photodynamic therapy vol.15, pp.6, 2016, https://doi.org/10.1039/C5PP00438A
- miR-655 suppresses epithelial-to-mesenchymal transition by targeting Prrx1 in triple-negative breast cancer vol.20, pp.5, 2016, https://doi.org/10.1111/jcmm.12770
- Targeting Cancer Metabolism - Revisiting the Warburg Effects vol.32, pp.3, 2016, https://doi.org/10.5487/TR.2016.32.3.177
- Roles of Dietary Phytoestrogens on the Regulation of Epithelial-Mesenchymal Transition in Diverse Cancer Metastasis vol.8, pp.6, 2016, https://doi.org/10.3390/toxins8060162
- Mitochondrial transcription factor A (TFAM) is upregulated in glioma vol.15, pp.6, 2017, https://doi.org/10.3892/mmr.2017.6467
- Reduced Autophagy in 5-Fluorouracil Resistant Colon Cancer Cells vol.25, pp.3, 2017, https://doi.org/10.4062/biomolther.2016.069
- Recognition of Transmembrane Protein 39A as a Tumor-Specific Marker in Brain Tumor vol.33, pp.1, 2017, https://doi.org/10.5487/TR.2017.33.1.063
- Curcumin reverses irinotecan resistance in colon cancer cell by regulation of epithelial–mesenchymal transition vol.29, pp.4, 2018, https://doi.org/10.1097/CAD.0000000000000599
- Epithelial–mesenchymal-transition-inducing transcription factors: new targets for tackling chemoresistance in cancer? pp.1476-5594, 2018, https://doi.org/10.1038/s41388-018-0378-x
- Killed Whole-Cell Oral Cholera Vaccine Induces CCL20 Secretion by Human Intestinal Epithelial Cells in the Presence of the Short-Chain Fatty Acid, Butyrate vol.9, pp.1664-3224, 2018, https://doi.org/10.3389/fimmu.2018.00055
- LIMK/cofilin pathway and Slingshot are implicated in human colorectal cancer progression and chemoresistance vol.472, pp.5, 2018, https://doi.org/10.1007/s00428-018-2298-0
- Study of New Therapeutic Strategies to Combat Breast Cancer Using Drug Combinations vol.8, pp.4, 2018, https://doi.org/10.3390/biom8040175
- The Phenolic compound Kaempferol overcomes 5-fluorouracil resistance in human resistant LS174 colon cancer cells vol.9, pp.1, 2019, https://doi.org/10.1038/s41598-018-36808-z